Outpatient chemotherapy, family-centered care, electronic information, and education in adolescents and young adults with osteosarcoma

References

• Johnson B, Ford D, Abraham M. Collaborating with patients and their families. J Healthc Risk Manag. 2010;29(4):15–21.
   Google Scholar
• Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ. 2007;335(7609):24–27.
   PubMed Web of Science ®Google Scholar
• Johnson BH, Abraham MR, Shelton TL. Patient- and family-centered care : partnerships for quality and safety. N C Med J. 2009;70(2):125–130.
   PubMedGoogle Scholar
• Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28(15):2625–2634.
   PubMed Web of Science ®Google Scholar
• Anderson P, Salazar-Abshire M. Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives. Curr Oncol Rep. 2006;8(6):415–222.
   Google Scholar
• Wexler LH, Andrich MP, Venzon D, et al. Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996;14(2):362–372.
   PubMed Web of Science ®Google Scholar
• Huh WW, Jaffe N, Durand JB, Munsell MF, Herzog CE. Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion. Pediatr Hematol Oncol. 2010;27(7):546–557.
   PubMed Web of Science ®Google Scholar
• Anderson P. Continuously improving ifosfamide/mesna: a winning combination. Pediatr Blood Cancer. 2010;55(4):599–600.
   Web of Science ®Google Scholar
• Goorin AM, Harris MB, Bernstein M, et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a Pediatric Oncology Group trial. J Clin Oncol. 2002;20(2):426–433.
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Hamdan H, Thompson RC Jr. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas. Cancer. 1993;72(10):2963–2969.
   PubMed Web of Science ®Google Scholar
• Aguilera D, Hayes-Jordan A, Anderson P, Woo S, Pearson M, Green H. Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor. Sarcoma. 2008;2008:261589.
   PubMedGoogle Scholar
• Anderson P, Aguilera D, Pearson M, Woo S. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radio- sensitizing agents. Cancer Control. 2008;15(1):38–46.
   Google Scholar
• Anderson PM, Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol Rep. 2006;8(4):310–315.
   Google Scholar
• Meazza C, Casanova M, Luksch R, et al. Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: feasibility and efficacy in refractory pediatric sarcoma. Pediatr Blood Cancer. 2010;55(4):617–620.
   PubMed Web of Science ®Google Scholar
• Meazza C, Bisogno G, Casanova M, Zanetti I, Carli M, Ferrari A. Full-dose ifosfamide can be safely administered to outpatients. Pediatr Blood Cancer. 2008;50(2):375–378.
   Web of Science ®Google Scholar
• Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9):630–641.
   PubMed Web of Science ®Google Scholar
• Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer. 1992;69(3):698–708.
   Web of Science ®Google Scholar
• Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 1998;80(7):1020–1033.
   Google Scholar
• Hendershot E, Pappo A, Malkin D, Sung L. Tumor necrosis in pediatric osteosarcoma: impact of modern therapies. J Pediatr Oncol Nurs. 2006;23(4):176–181.
   Google Scholar
• Moore C, Eslin D, Levy A, Roberson J, Giusti V, Sutphin R. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma. Pediatr Blood Cancer. 2010;55(6):1096–1102.
   Web of Science ®Google Scholar
• Anderson P. Predicting and facilitating survival of pediatric cancer patients: the ALC story. Pediatr Blood Cancer. 2010;55(6):1041–1042.
   Web of Science ®Google Scholar
• Smith TJ, Hillner BE. Concrete options and ideas for increasing value in oncology care: the view from one trench. Oncologist. 2010;15 Suppl 1:65–72.
   Google Scholar